Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-CACI 2024 Congresses
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
El Salvador 2024 Sessions
Arequipa 2024 Sessions
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/IASC Clinical Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Related Organizations
Institutional News
Contact
Search
Buscar
Buscar
Congreso SOLACI
SOLACI-CACI 2024
Certificados SOLACI-CACI 24
Presentaciones destacadas día 1
Presentaciones destacadas día 2
Presentaciones destacadas día 3
Notas y cobertura
Facebook
Instagram
Linkedin
Twitter
Youtube
Home
Novedades Científicas
Cardiopatía estructural
Enfermedad coronaria
Enfermedad vascular periférica
Farmacología
Boletines educativos para fellows
Webinars educativos
Otras publicaciones
Congresos
Congreso SOLACI-CACI 2024
Congresos internacionales
Congresos SOLACI
Próximos eventos
Áreas SOLACI
Jornadas
Jornadas El Salvador 2024
Jornadas Arequipa 2024
Jornadas Realizadas
Acerca de Jornadas
Autoridades
Novedades
ProEducar
Boletines Educativos
Cursos de Fellows
Rincón del Fellow
Videos y Webinars ProEducar
Novedades
SOLACI Research
Registro LATAM-SOLACI Peripheral
Registro LATAM Bif-SOLACI
Sea parte de nuestros registros
Guías Clínicas SOLACI / SIAC
Autoridades
Videos y Webinars
Novedades
SOLACI Peripheral
Registro LATAM-SOLACI Peripheral
Videos y Webinars
Autoridades
Novedades
Grupo MIL
Actividades e iniciativas
Videos y Webinars
Historia, misión y visión
Autoridades
CHIP LATAM
Autoridades
Novedades
SOL SOLACI
Autoridades
Cardiopatías Congénitas
Autoridades
Novedades Cardiopatías Congénitas
Técnicos y Enfermeros
Autoridades
Webinars y videos
Novedades
Acerca de SOLACI
Quiénes somos
Comisión directiva
Directorio de profesionales
Asóciese a SOLACI
Sociedades vinculadas
Noticias Institucionales
Contacto
Home
Novedades Científicas
Cardiopatía estructural
Enfermedad coronaria
Enfermedad vascular periférica
Farmacología
Boletines educativos para fellows
Webinars educativos
Otras publicaciones
Congresos
Congreso SOLACI-CACI 2024
Congresos internacionales
Congresos SOLACI
Próximos eventos
Áreas SOLACI
Jornadas
Jornadas El Salvador 2024
Jornadas Arequipa 2024
Jornadas Realizadas
Acerca de Jornadas
Autoridades
Novedades
ProEducar
Boletines Educativos
Cursos de Fellows
Rincón del Fellow
Videos y Webinars ProEducar
Novedades
SOLACI Research
Registro LATAM-SOLACI Peripheral
Registro LATAM Bif-SOLACI
Sea parte de nuestros registros
Guías Clínicas SOLACI / SIAC
Autoridades
Videos y Webinars
Novedades
SOLACI Peripheral
Registro LATAM-SOLACI Peripheral
Videos y Webinars
Autoridades
Novedades
Grupo MIL
Actividades e iniciativas
Videos y Webinars
Historia, misión y visión
Autoridades
CHIP LATAM
Autoridades
Novedades
SOL SOLACI
Autoridades
Cardiopatías Congénitas
Autoridades
Novedades Cardiopatías Congénitas
Técnicos y Enfermeros
Autoridades
Webinars y videos
Novedades
Acerca de SOLACI
Quiénes somos
Comisión directiva
Directorio de profesionales
Asóciese a SOLACI
Sociedades vinculadas
Noticias Institucionales
Contacto
Home
International Congresses
AHA 2018
AHA 2018
STRUCTURAL HEART DISEASE
PHARMACOLOGY
CORONARY DISEASE
Ver Categoría
Other
AHA 2018 | PIONEER-HF: Sacubitril/Valsartan in Acute Decompensated Heart Failure
Treating acute decompensated heart failure patients with an angiotensin receptor inhibitor plus a neprilysin receptor inhibitor significantly...
solaci
-
30 November, 2018
Ver más
CORONARY DISEASE
AHA 2018 | New-Generation DES Are Similar to Second-Generation DES Beyond Polymer
Sirolimus-eluting stents with biodegradable polymer did not offer better outcomes compared with instant-classic (and undoubtedly valid) everolimus-eluting...
solaci
-
30 November, 2018
Ver más
Acute coronary syndromes
AHA 2018 | More Evidence for the Impella Device, But Larger Trials Are Necessary
In this pilot study, unloading the left ventricle with the Impella CP circulatory support device and delaying angioplasty...
solaci
-
30 November, 2018
Ver más
Other
AHA 2018 | New Dyslipidemia Guidelines Support Non-Statin Therapy and Coronary Artery Calcium Screening
While the guidelines do not recommend a specific treatment target, they suggest additional therapy in high-risk patients...
solaci
-
30 November, 2018
Ver más
Other
AHA 2018 | No Benefits with Methothrexate as Anti-Inflammatory Drug
Low-dose methotrexate (a nonspecific anti-inflammatory agent used for the treatment of rheumatoid arthritis and other autoimmune disorders)...
solaci
-
28 November, 2018
Ver más
Chronic Ischemic cardiopathy
AHA 2018 | Endoscopic Saphenous-Vein-Graft Harvesting in Patients Undergoing Myocardial Revascularization Surgery
For patients undergoing myocardial revascularization surgery, endoscopic harvesting of saphenous veins in expert hands is similar to...
solaci
-
28 November, 2018
Ver más
Chronic Ischemic cardiopathy
AHA 2018 | New Physical Activity Guidelines Recommend Movement for All Ages
The new 2018 physical activity guidelines continue to recommend the same amount of physical activity (300 minutes of...
solaci
-
28 November, 2018
Ver más
Other
AHA 2018 | Canakinumab Reduces Hospitalization for Cardiac Failure in Respondents
The benefit was dose-dependent reduction, regardless the presence of absence of baseline cardiac failure. Patients with prior...
solaci
-
27 November, 2018
Ver más